雜志介紹

Cancer Science雜志介紹

《Cancer Science》是(shi)一(yi)本(ben)以(yi)English為主的(de)(de)(de)(de)開放獲(huo)取國際(ji)優秀期刊，中文名稱(cheng)癌癥(zheng)科(ke)學，本(ben)刊主要出版、報道醫(yi)學-ONCOLOGY領域的(de)(de)(de)(de)研究動態以(yi)及在(zai)該(gai)領域取得的(de)(de)(de)(de)各方面的(de)(de)(de)(de)經驗和(he)科(ke)研成果，介紹該(gai)領域有關本(ben)專業(ye)的(de)(de)(de)(de)最新(xin)進展，探討(tao)行業(ye)發展的(de)(de)(de)(de)思路(lu)和(he)方法，以(yi)促進學術信息交(jiao)流，提高行業(ye)發展。該(gai)刊已被國際(ji)權威(wei)數(shu)據庫SCIE收錄，為該(gai)領域相關學科(ke)的(de)(de)(de)(de)發展起到(dao)了良好的(de)(de)(de)(de)推動作用(yong)，也得到(dao)了本(ben)專業(ye)人員(yuan)的(de)(de)(de)(de)廣泛認可。該(gai)刊最新(xin)影(ying)響因子(zi)為4.5，最新(xin)CiteScore 指數(shu)為9.9。

本(ben)刊近期(qi)中(zhong)國學者(zhe)發表(biao)的論文主要(yao)有：

• Distinct mechanisms of dysfunctional antigen-presenting DCs and monocytes by single-cell sequencing in multiple myeloma

  Author: Jiang, Jinxing; Xiang, Jing; Chen, Mengping; Wan, Yike; Zhong, Lu; Han, Xiaofeng; Chen, Xiaotong; Wang, Junying; Xiao, Fei; Liu, Jia; Li, Hua; Huang, Honghui; Hou, Jian

• Targeting the PTP1B-Bcr-Abl1 interaction for the degradation of T315I mutant Bcr-Abl1 in chronic myeloid leukemia

  Author: Elgehama, Ahmed; Wang, Yixuan; Yu, Ying; Zhou, Lin; Chen, Zhixiu; Wang, Liwei; Sun, Lijun; Gao, Jian; Yu, Biao; Shen, Yan; Xu, Qiang

• Hypoxia-induced CXC chemokine ligand 14 expression drives protumorigenic effects through activation of insulin-like growth factor-1 receptor signaling in glioblastoma

  Author: Wei, Sung-Tai; Chiang, Jung-Ying; Wang, Hwai-Lee; Lei, Fu-Ju; Huang, Yen-Chih; Wang, Chi-Chung; Cho, Der-Yang; Hsieh, Chia-Hung

• METTL3-mediated m6A mRNA contributes to the resistance of carbon-ion radiotherapy in non-small-cell lung cancer

  Author: Xu, Xiaofeng; Zhang, Peiru; Huang, Yangle; Shi, Weizhong; Mao, Jingfang; Ma, Ningyi; Kong, Lin; Guo, Lin; Liu, Jinlong; Chen, Jian; Lu, Renquan

英文介紹

Cancer Science雜志英文介紹

Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports.

Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.